Yves Fomekong Nanfack is Head of AI/ML Research at Takeda Pharmaceutical Company, based in Cambridge, MA, with global responsibilities spanning computational biology, large molecule discovery, agentic AI, and foundational model strategy. He holds a PhD in Applied Mathematics/AI and an MSc in Computer Science, with prior leadership roles at Sanofi (Head of AI End-to-End Foundations) and Merck/EMD Serono. His work centers on an "in-silico first," AI-native approach to drug discovery, with particular depth in antibody engineering, TIDVAL, and scientist-empowering AI platforms.